← Every applicant
Marksans Pharma FDA Approvals
9 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| BENZONATATENew drugMar 30, 2026CAPSULE, ORAL |
| LOPERAMIDE HYDROCHLORIDENew drugNov 17, 2025TABLET, ORAL |
| OMEPRAZOLE MAGNESIUMNew drugAug 7, 2025TABLET, DELAYED RELEASE, ORAL |
| LORATADINENew drugNov 21, 2024TABLET, ORAL |
| ESOMEPRAZOLE MAGNESIUMNew drugSep 29, 2023CAPSULE, DELAYED RELEASE, ORAL |
| GUAIFENESINNew drugAug 21, 2023TABLET, EXTENDED RELEASE, ORAL |
| ACETAMINOPHEN AND IBUPROFENNew drugJul 10, 2023TABLET, ORAL |
| FAMOTIDINENew drugMar 8, 2023TABLET, ORAL |
| ACETAMINOPHENNew drugAug 25, 2021TABLET, EXTENDED RELEASE, ORAL |